FDA Referred 6 drug compounding facilities to state boards of pharmacies last month: All eyes are on the state boards of to see what, if anything, they will do!

FDA Refers Some Patient-Specific Compounders To States For Oversight
FDA last month referred six drug compounding facilities to state authorities after inspections showed sterility concerns with drugs produced under patient prescription records, according to agency documents.
quoted from here